Prognostication of the High-Risk WM Patient
- 1 February 2011
- journal article
- Published by Elsevier BV in Clinical Lymphoma Myeloma and Leukemia
- Vol. 11 (1), 127-129
- https://doi.org/10.3816/clml.2011.n.028
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH)Leukemia Research, 2010
- International prognostic scoring system for Waldenström macroglobulinemiaBlood, 2009
- Diagnosis and Management of Waldenstrom's MacroglobulinemiaJournal of Clinical Oncology, 2005
- Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: Consensus Panel Recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaSeminars in Oncology, 2003